The page is the record's research on the issuer — no analyst, no rating, no view.

Editas Medicine, Inc. (EDIT) — research page

US · us-cm-kg/NASDAQ/EDIT · as of 2026-11-08

Identity and listing

The issuer is Editas Medicine, Inc., listed on NASDAQ under ticker EDIT, with ISIN US28106W1036 and LEI 5299000AON4Q9NT2JE42. The security type is Corporate. The segment is not on the record. The sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted.

fieldvaluesource · read date
nameEditas Medicine, Inc.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerEDITsource · 2026-11-08
ISINUS28106W1036source · 2026-11-08
LEI5299000AON4Q9NT2JE42source · 2026-11-08
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2836 Biological Products, (No Diagnostic Substances)source · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 66 filings across 32 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 7 days. The latest filing is dated 2026-11-06, two days before the record date of 2026-11-08, and is of type directors_dealings. Filings by type are: 28 directors_dealings, 16 regulatory_filing, 8 results, 6 corporate_news, 4 prospectus, 3 agm_egm, and 1 director_change. On NASDAQ, the median filings count is 52, the median cadence gap is 6.0 days, and the median latency is 5.0 days across 4359 issuers. In the sector, the median filings count is 65.5, the median cadence gap is 5.5 days, and the median latency is 4.0 days across 176 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer6672
exchange median: NASDAQ (4359 issuers)5265
sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers)65.55.54
datetypecategoryfiling
2026-11-06directors_dealings44 — FORM 4
2026-11-06directors_dealings44 — FORM 4
2026-10-27regulatory_filingSCHEDULE 13GSCHEDULE 13G
2026-10-08corporate_news8-K8-K — 8-K (items 7.01,8.01,9.01)
2026-09-09directors_dealings44 — FORM 4

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Ernst & Young LLP, located in Boston, Massachusetts. The record holds one auditor change, dated 2026-04-07.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

Open research

No openly published research notes were found on the record. The count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001650664.json (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://mcp.us-cm-kg.ai/events/NASDAQ/EDIT (the disclosure lines)
10.6
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.7
https://www.sec.gov/Archives/edgar/data/1650664/000165066426000017/edit-20251231.htm (the auditor)
10.8
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.9
https://mcp.us-cm-kg.ai/record/NASDAQ/EDIT (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US28106W1036"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f279597dbfaf4eca.